TWD 24.5
(1.24%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 420.28 Million TWD | -23.93% |
2022 | 552.5 Million TWD | -0.77% |
2021 | 556.79 Million TWD | 48.0% |
2020 | 376.2 Million TWD | 7.24% |
2019 | 350.81 Million TWD | -4.05% |
2018 | 365.62 Million TWD | 3.87% |
2017 | 351.99 Million TWD | 12.16% |
2016 | 313.83 Million TWD | -0.59% |
2015 | 315.71 Million TWD | 16.71% |
2014 | 270.5 Million TWD | 8.13% |
2013 | 250.16 Million TWD | 4.79% |
2012 | 238.73 Million TWD | 8.35% |
2011 | 220.32 Million TWD | 35.28% |
2010 | 162.86 Million TWD | 42.53% |
2009 | 114.26 Million TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 433.36 Million TWD | 3.11% |
2024 Q2 | 444.65 Million TWD | 2.6% |
2023 Q3 | 436.5 Million TWD | -1.74% |
2023 Q1 | 546.16 Million TWD | -1.15% |
2023 FY | 420.28 Million TWD | -23.93% |
2023 Q4 | 420.28 Million TWD | -3.71% |
2023 Q2 | 444.23 Million TWD | -18.66% |
2022 Q3 | 622.26 Million TWD | 1.46% |
2022 FY | 552.5 Million TWD | -0.77% |
2022 Q4 | 552.5 Million TWD | -11.21% |
2022 Q1 | 612.81 Million TWD | 10.06% |
2022 Q2 | 613.33 Million TWD | 0.08% |
2021 FY | 556.79 Million TWD | 48.0% |
2021 Q3 | 562.13 Million TWD | 20.04% |
2021 Q4 | 556.79 Million TWD | -0.95% |
2021 Q1 | 442.74 Million TWD | 17.69% |
2021 Q2 | 468.3 Million TWD | 5.77% |
2020 Q2 | 382.8 Million TWD | 23.56% |
2020 FY | 376.2 Million TWD | 7.24% |
2020 Q3 | 437.66 Million TWD | 14.33% |
2020 Q4 | 376.2 Million TWD | -14.04% |
2020 Q1 | 309.8 Million TWD | -11.69% |
2019 Q1 | 424.12 Million TWD | 16.0% |
2019 Q3 | 428.17 Million TWD | 0.53% |
2019 Q4 | 350.81 Million TWD | -18.07% |
2019 FY | 350.81 Million TWD | -4.05% |
2019 Q2 | 425.93 Million TWD | 0.43% |
2018 Q2 | 338.96 Million TWD | -5.5% |
2018 Q3 | 386.09 Million TWD | 13.9% |
2018 Q4 | 365.62 Million TWD | -5.3% |
2018 Q1 | 358.69 Million TWD | 1.9% |
2018 FY | 365.62 Million TWD | 3.87% |
2017 Q1 | 337.49 Million TWD | 7.54% |
2017 FY | 351.99 Million TWD | 12.16% |
2017 Q4 | 351.99 Million TWD | -10.73% |
2017 Q3 | 394.29 Million TWD | 6.49% |
2017 Q2 | 370.27 Million TWD | 9.71% |
2016 Q2 | 310.73 Million TWD | 6.23% |
2016 Q3 | 349.36 Million TWD | 12.43% |
2016 Q4 | 313.83 Million TWD | -10.17% |
2016 Q1 | 292.5 Million TWD | -7.35% |
2016 FY | 313.83 Million TWD | -0.59% |
2015 FY | 315.71 Million TWD | 16.71% |
2015 Q4 | 315.71 Million TWD | -0.53% |
2015 Q3 | 317.4 Million TWD | 19.31% |
2015 Q1 | 288.43 Million TWD | 6.63% |
2015 Q2 | 266.02 Million TWD | -7.77% |
2014 Q2 | 313.55 Million TWD | 2.39% |
2014 FY | 270.5 Million TWD | 8.13% |
2014 Q1 | 306.23 Million TWD | 22.41% |
2014 Q3 | 321.38 Million TWD | 2.5% |
2014 Q4 | 270.5 Million TWD | -15.83% |
2013 Q1 | 221.82 Million TWD | -7.08% |
2013 FY | 250.16 Million TWD | 4.79% |
2013 Q4 | 250.16 Million TWD | 1.04% |
2013 Q3 | 247.59 Million TWD | 3.04% |
2013 Q2 | 240.28 Million TWD | 8.32% |
2012 Q1 | 202.14 Million TWD | -8.25% |
2012 FY | 238.73 Million TWD | 8.35% |
2012 Q4 | 238.73 Million TWD | -11.28% |
2012 Q3 | 269.08 Million TWD | 9.22% |
2012 Q2 | 246.36 Million TWD | 21.88% |
2011 Q2 | 181.61 Million TWD | 3.36% |
2011 FY | 220.32 Million TWD | 35.28% |
2011 Q1 | 175.71 Million TWD | 7.89% |
2011 Q3 | 267.67 Million TWD | 47.38% |
2011 Q4 | 220.32 Million TWD | -17.69% |
2010 FY | 162.86 Million TWD | 42.53% |
2010 Q4 | 162.86 Million TWD | 0.0% |
2009 FY | 114.26 Million TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Excelsior Medical Co., Ltd. | 1.24 Billion TWD | 66.308% |
OK Biotech Co., Ltd. | 394.04 Million TWD | -6.66% |
Applied BioCode Corporation | 174.97 Million TWD | -140.201% |